Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Servier Research Institute of Medicinal Chemistry (SRIMC) is a premier drug discovery center located in Budapest, Hungary, and serves as a vital component of the global Servier Group's R&D network. Established in 2007, the institute focuses on medicinal chemistry, organic synthesis, and early-stage discovery of innovative small molecule therapeutics. SRIMC leverages Hungary's deep expertise in chemical sciences to support Servier's core therapeutic areas, including oncology, neuroscience, and cardiovascular diseases. The institute is responsible for the design and synthesis of numerous chemical entities that have progressed into Servier's clinical pipeline. As the largest private research institute in Hungary, it maintains extensive collaborations with local academic institutions and international partners. Its work is central to Servier's mission of providing innovative treatments for patients with high unmet medical needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Servier Research Institute of Medicinal Chemistry.